News
Novo Nordisk faces challenges in the competitive GLP-1 market, but its strong brand and R&D create opportunities for ...
Wild birds chirp inside a dense grove of magnolia trees shading a new home near downtown Fayetteville. The pale gray two-story Prairie-style single-family residence, appropriately named Magnolia House ...
The best stocks to invest in often are industry leaders in vast markets. These five stocks are likely to continue making ...
From the wind farms of Jutland to the rising skyline of NEOM, Denmark and Saudi Arabia are edging toward a new phase in their ...
BP named a new board chair after activist shareholders pressured the company to move in a new direction. The London-based ...
A research team engineered thymidine auxotrophic and recombination-deficient versions of commonly used and underutilized ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
A genetic test may one day predict a child’s risk of obesity in adulthood, paving the way for early interventions ...
Daniel Drucker, Ozempic’s father: ‘I’m very conservative. I don’t sell the drugs. I study the drugs’
The Canadian researcher has just received the Frontiers of Knowledge Award for his work on anti-obesity drugs. However, he ...
3d
Tasting Table on MSN15 Coffee Cities Around The World You Should Know AboutFrom the Americas to Asia and Africa, coffee culture is thriving around the world. These international cities are your best ...
Alva Health CEO and Mexican immigrant Sandra Saldana aims to provide early detection for a leading cause of death and ...
Some health experts view GLP-1s as a promising option for PCOS, which lacks a standard treatment and affects millions of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results